Clinical Research Centre
Hospital Seberang Jaya
Perai, Pulau Pinang
WhoWe Are
Launched in 2011, Clinical Research Centre Hospital Seberang Jaya (CRC HSJ) has actively promoted and conducted clinical research through local and international collaborations, aligning with Malaysia's health research priorities. CRC HSJ offers training workshops in Evidence-Based Medicine (EBM), Good Clinical Practice (GCP), and research methodology, as well as providing research consultations. It supports Investigator Initiated Research (IIR) and Industry Sponsored Research (ISR), extending research support and training to three satellite hospitals. The hospital’s advanced facilities and diverse specialties helping to identify suitable patients for clinical trials.
OurTeam
| NMRR-20-2730-57378 | Pharmacokinetic Model Development of Insulin in Hyperglycemic Patient with Acute Ischaemic Stroke (GreenCare A1C) |
| NMRR-19-3823-52045 | A Prospective Observational Study to Evaluate the Effect of Sodium Dialysate Levels of 137mmol/L and 140mmol/L on Vascular Events in Patients on Maintenance Haemodialysis (Adapted from George Institute Protocol V3.0-01 August 2017) RESOLVE |
| NMRR-22-02260-DHZ | Attitudes and Beliefs to Use of Medical Cannabis among Malaysian's Doctors |
| NMRR-22-01199-TGT | Tranexamic Acid for Hyperacute Spontaneous IntraCerebral Haemorrhage (TICH-3) |
| NMRR-20-2706-57567 | Assessment of Knowledge of Acute Ischaemic Stroke Management among Healthcare Professionals Pre and Post Online Stroke Certification Modules |
| NMRR-21-99-58265 | The Assessment of Doctors' Knowledge, Practice and Barriers of Evidence-Based Medicine (EBM) in Hospital Seberang Jaya |
| NMRR-20-1140-53693 | Treatment of CVD with Low Dose Rivaroxaban in Advanced CKD (TRACK) |
| NMRR-20-2749-57043 | Quality of Life among Polycystic Ovary Syndrome (PCOS) Patients in Tertiary Care Hospitals |
| NMRR-20-1213-55165 | Stroke Care Performance Measures Survey: A Malaysian District Hospital Experience |
| NMRR-20-1476-55732 | A Stroke Study Project from Hospital Seberang Jaya |
| RSCH-21-00775-GLY | Telemedicine Tool for Acute Stroke Management: JOIN Apps |
| NMRR-23-03211-FYK | An Audit on The Use of Alteplase Injection for Thrombolysis in Hospital Seberang Jaya |
| NMRR-22-00677-XB8 | Association between Serum Uric Acid Levels and Perinatal Outcome in Women with Preeclampsia in Hospital Seberang Jaya |
| NMRR-23-02085-IH7 | Open, Randomized, Parallel Group Study to Assess Efficacy, Safety, and Tolerability of Repeat Doses of Vaginal Hyaluronic (V-HYAL) Gel in Peri- and Post-Menopausal Female |
| NMRR-23-01716-LOU | Whole Exome Sequencing in Late Onset Alzheimer’s Disease in Peninsular Malaysia |
| RSCH-22-03853-8NA | Development of a Mortality Risk Score to Assess The Risk of Dying Through Antibiotics De-escalation Therapy in Patients |
| NMRR-21-1851-61427 |
Prescribing Trends and Adverse Drug Reaction in Stroke Patients in Hospital Seberang Jaya
|
| NMRR-22-00419-YJ4 | REMODEL-1: A Randomized, Double-Blind, Double Dummy, Parallel-Group Study, Comparing The Efficacy and Safety of Remibrutinib 100mg b.i.d. Versus Teriflunomide 14mg q.d. in Participants with Relapsing Multiple Sclerosis, Followed by Extended Treatment with Open-Label Remibrutinib. |
| NMRR-20-1762-55983 | A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared with Teriflunomide, in Participants with Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety. |
| NMRR-20-2801-57010 | A Phase 2b/3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-1654 in Healthy Pre-Term and Full-Term Infants |
| NMRR-21-760-59664 | Effects of Ziltivekimab versus placebo on cardiovascular outcomes in participants with established atherosclerotic cardiovascular disease, chronic kidney disease and systemic inflammation (ZEUS). |
| NMRR-22-02248-12G/S8 | A multicenter, international, randomized, active comparator-controlled, double-blind, double-dummy, parallel group, 2-arm Phase 3 study to compare the efficacy and safety of the oral FXIa inhibitor asundexian (BAY 2433334) with apixaban for the prevention of stroke or systemic embolism in male and female participants aged 18 years and older with atrial fibrillation at risk for stroke |
| NMRR-23-00649-ZCJ | A Phase 3, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, after an Ischemic Stroke or High Risk Transient Ischemic Attack |
| NMRR-23-00643-MQM | A Phase I/III Randomized, Double blind Study to Evaluate the Safety and Neutralizing Activity of AZD5156 for Pre exposure Prophylaxis of COVID 19 in Participants with Conditions Causing Immune Impairment |
| NMRR-22-023538-FTQ/S1 | A multicenter, international, randomized, placebo controlled,double blind, parallel group and event driven Phase 3 study of the oral Fxla inhibitor asundexian (BAY 2433334) for the prevention of ischaemic stroke in male and female participants aged 18 years and older after an acute non-cardioembolic ischemic stroke or high-risk TIA |
| NMRR-23-01803-SNW | A randomized, subject- and investigator-blinded, placebo-controlled, parellel group study to assess the efficacy, safety and pharmacokinetics of EYU688 in subjetcs with dengue fever (CEYU688A12201) - Phase 2 |
| NMRR-23-00644-HN1 | A Phase 3, Randomized, Double-blind, Placebo-controlled, Event-driven Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, After a Recent Acute Coronary Syndrome. |
| NMRR-24-01164-AHR | A multicenter, double-blinded, placebo-controlled, single ascending dose, two-part, randomized, phase 2 clinical trial to assess safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of BB-031 in acute ischemic stroke (AIS) patients. |
Services at CRC Hospital Seberang Jaya
CRC HSJ provides training through workshops and consultations:
- Good Clinical Practice (GCP)
- Scoping review
- Evidence-Based Medicine (EBM)
- Introduction to Clinical Research
- Case study writing workshop
- Research methodology
- Biostatistics
- National Conference for Clinical Research (NCCR)
- Statistical software (SPSS, STATA)
- National Medical Research Register (NMRR) hands-on
- Health system research
- Protocol development workshop
- Systematic review
Research Facilities
Further info on upcoming activities
CRC Hospital Seberang Jaya, Perai, Pulau Pinang
Clinical Research Centre,
Hospital Seberang Jaya,
Jalan Tun Hussein Onn,
Seberang Jaya,
13700 Perai, Pulau Pinang
Main Phone: +604-3827333 Ext: 511
Fax: +604-3902192
Fax: +604-3902192
